Filing Details
- Accession Number:
- 0000899243-15-010072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-17 19:01:19
- Reporting Period:
- 2015-12-15
- Filing Date:
- 2015-12-17
- Accepted Time:
- 2015-12-17 19:01:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594864 | Juno Therapeutics Inc. | JUNO | Biological Products, (No Disgnostic Substances) (2836) | 463656275 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591178 | Richard Klausner | 307 Westlake Avenue North, Suite 300 Seattle WA 98109 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-12-15 | 4,215 | $44.81 | 926,284 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-15 | 3,700 | $45.74 | 922,584 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-12-15 | 4,085 | $46.62 | 918,499 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $44.23 to $45.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $45.23 to $46.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $46.23 to $47.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2015, as amended August 14, 2015.
Billionaire Hedge Funds
